Illicit use of Methylphenidate: the other side of the medical prescription
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://doi.org/10.25753/BirthGrowthMJ.v27.i2.13022 |
Resumo: | Introduction/Objective: Attention Deficit Hyperactivity Disorder is the most common neurobehavioral disorder of childhood. Parallel to the progress in the diagnosis, the prescription of psychostimulants, namely Methylphenidate (MPH), has also increased. The aim of this review is to promote reflection and debate on this issue, displaying its actual relevance in order to prevent and properly diagnose such cases in Portugal. Results: In recent years, illicit use or misuse of MPH for recreational purposes or as a cognitive stimulant to improve academic achievement, has become a focus of concern. Easier accessibility, false belief that it is safer than illegal drugs because it’s prescription based as well a less social stigmatization promote this practice. Thus, treatment with MPH requires adequate medical indication and supervision, not only for its potential cardiovascular side effects and exacerbation of psychiatric disorders, but also due to the risk of illicit use and intoxication. Conclusion: This article reviews the literature concerning MPH misuse. In order to counteract this emerging problem, of still unknown proportions in Portugal, it is crucial to invest in the information and awareness of adolescents, parents, health professionals, and educational community in general. |
id |
RCAP_7fd9cee67538fbb576d737d96f3cef95 |
---|---|
oai_identifier_str |
oai:ojs.revistas.rcaap.pt:article/13022 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Illicit use of Methylphenidate: the other side of the medical prescriptionUso ilícito de metilfenidato: o outro lado da prescrição médicaReview ArticlesIntroduction/Objective: Attention Deficit Hyperactivity Disorder is the most common neurobehavioral disorder of childhood. Parallel to the progress in the diagnosis, the prescription of psychostimulants, namely Methylphenidate (MPH), has also increased. The aim of this review is to promote reflection and debate on this issue, displaying its actual relevance in order to prevent and properly diagnose such cases in Portugal. Results: In recent years, illicit use or misuse of MPH for recreational purposes or as a cognitive stimulant to improve academic achievement, has become a focus of concern. Easier accessibility, false belief that it is safer than illegal drugs because it’s prescription based as well a less social stigmatization promote this practice. Thus, treatment with MPH requires adequate medical indication and supervision, not only for its potential cardiovascular side effects and exacerbation of psychiatric disorders, but also due to the risk of illicit use and intoxication. Conclusion: This article reviews the literature concerning MPH misuse. In order to counteract this emerging problem, of still unknown proportions in Portugal, it is crucial to invest in the information and awareness of adolescents, parents, health professionals, and educational community in general.Introdução/Objetivo: A Perturbação de Hiperatividade com Défice de Atenção é a perturbação neurocomportamental mais frequente na criança em idade escolar. Paralelamente ao aumento do seu diagnóstico, também a prescrição de psicoestimulantes, nomeadamente o Metilfenidato (MFD), tem aumentado. O objetivo desta revisão é promover a reflexão e discussão sobre esta problemática, salientando a sua relevância atual, bem como a necessidade de prevenção e diagnóstico adequado destes casos em Portugal. Resultados: Nos últimos anos, o uso ilícito de MFD para fins recreativos ou como estimulante cognitivo para melhorar os resultados académicos, tornou-se num foco de preocupação. A acessibilidade facilitada, a falsa crença de que por ser prescrito é mais seguro do que drogas ilegais e a menor estigmatização social promovem esta prática. Assim, o tratamento com MFD requer uma indicação médica e vigilância adequadas, não só pelos seus potenciais efeitos secundários cardiovasculares e exacerbação de transtornos psiquiátricos, mas também pelo risco de uso ilícito e intoxicação. Conclusão: Este artigo revê a literatura relativa à problemática do uso ilícito de MFD. Para combater este problema emergente, cuja dimensão ainda é desconhecida em Portugal, é crucial investir na informação e consciencialização dos adolescentes, pais, profissionais de saúde e comunidade educativa em geral.Centro Hospitalar Universitário do Porto2018-07-13T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttps://doi.org/10.25753/BirthGrowthMJ.v27.i2.13022eng2183-9417Pereira, Sandra Vanessa DiasFerreira, Ana MariaAzevedo, AnaBarroso, CláudiaMonteiro, Virgíniainfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2022-09-21T14:55:27Zoai:ojs.revistas.rcaap.pt:article/13022Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T15:56:25.421347Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Illicit use of Methylphenidate: the other side of the medical prescription Uso ilícito de metilfenidato: o outro lado da prescrição médica |
title |
Illicit use of Methylphenidate: the other side of the medical prescription |
spellingShingle |
Illicit use of Methylphenidate: the other side of the medical prescription Pereira, Sandra Vanessa Dias Review Articles |
title_short |
Illicit use of Methylphenidate: the other side of the medical prescription |
title_full |
Illicit use of Methylphenidate: the other side of the medical prescription |
title_fullStr |
Illicit use of Methylphenidate: the other side of the medical prescription |
title_full_unstemmed |
Illicit use of Methylphenidate: the other side of the medical prescription |
title_sort |
Illicit use of Methylphenidate: the other side of the medical prescription |
author |
Pereira, Sandra Vanessa Dias |
author_facet |
Pereira, Sandra Vanessa Dias Ferreira, Ana Maria Azevedo, Ana Barroso, Cláudia Monteiro, Virgínia |
author_role |
author |
author2 |
Ferreira, Ana Maria Azevedo, Ana Barroso, Cláudia Monteiro, Virgínia |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Pereira, Sandra Vanessa Dias Ferreira, Ana Maria Azevedo, Ana Barroso, Cláudia Monteiro, Virgínia |
dc.subject.por.fl_str_mv |
Review Articles |
topic |
Review Articles |
description |
Introduction/Objective: Attention Deficit Hyperactivity Disorder is the most common neurobehavioral disorder of childhood. Parallel to the progress in the diagnosis, the prescription of psychostimulants, namely Methylphenidate (MPH), has also increased. The aim of this review is to promote reflection and debate on this issue, displaying its actual relevance in order to prevent and properly diagnose such cases in Portugal. Results: In recent years, illicit use or misuse of MPH for recreational purposes or as a cognitive stimulant to improve academic achievement, has become a focus of concern. Easier accessibility, false belief that it is safer than illegal drugs because it’s prescription based as well a less social stigmatization promote this practice. Thus, treatment with MPH requires adequate medical indication and supervision, not only for its potential cardiovascular side effects and exacerbation of psychiatric disorders, but also due to the risk of illicit use and intoxication. Conclusion: This article reviews the literature concerning MPH misuse. In order to counteract this emerging problem, of still unknown proportions in Portugal, it is crucial to invest in the information and awareness of adolescents, parents, health professionals, and educational community in general. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-07-13T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://doi.org/10.25753/BirthGrowthMJ.v27.i2.13022 |
url |
https://doi.org/10.25753/BirthGrowthMJ.v27.i2.13022 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
2183-9417 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Centro Hospitalar Universitário do Porto |
publisher.none.fl_str_mv |
Centro Hospitalar Universitário do Porto |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799130432586907648 |